CAN Stop - psychoeducation and relapse prevention for young persons with problematic cannabis use
ISRCTN | ISRCTN57036983 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN57036983 |
Secondary identifying numbers | IIA5-2507DSM209 |
- Submission date
- 18/01/2011
- Registration date
- 10/03/2011
- Last edited
- 18/12/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Rainer Thomasius
Scientific
Scientific
DZSKJ
Martinistrasse 52
Hamburg
20246
Germany
thomasius@uke.uni-hamburg.de |
Study information
Study design | Four-arm randomised wait-list controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | CAN Stop - psychoeducation and relapse prevention for young persons with problematic cannabis use - development and evaluation of a preventive group-based training programme [Psychoedukation und Rückfallprävention für junge Menschen mit problematischem Cannabiskonsum Entwicklung und Evaluation eines Gruppenbehandlungsprogramms] |
Study acronym | CAN Stop |
Study objectives | We hypothesise that young cannabis users who participated at the preventive CAN Stop group training in addition to the treatment or service usually provided in the specific help provision context (e.g. drug addiction aid and youth welfare, in-patient medical context, out-patient medical context, juvenile prisons) show lower level of cannabis intake and higher levels of cannabis abstinence-related self-efficacy after the training as opposed to young cannabis users who received the usual treatment or service. |
Ethics approval(s) | 1. Ethics Committee of the Chamber of Physicians Hamburg approved on 3rd March 2009 (ref: PV3086) 2. Ethics Committee of the Schleswig-Holstein Chamber of Physicians approved on 6th May 2009 (ref: AZ 41/09) 3. Ethics Committee of the Chamber of Physicians North Rhine approved on 29th January 2010 (ref: 2009366) 4. Ethics Committee of the Chamber of Physicians Hesse approved on 2nd August 2010 (ref: MC 168/2010) |
Health condition(s) or problem(s) studied | Problematic cannabis use |
Intervention | The CAN Stop group training consists of eight group sessions of 90 minutes. Groups consist of six to ten young cannabis users and one or two trainers. The training's rationale is based on behavioural therapeutic and motivational interviewing elements. It encompasses consumer or craving diaries, the work with social and emotional context variables and potential triggers as well as the elaboration of alternative behaviour strategies and the activation of participants resources. Generally and for motivational reasons, it is left open to participants within the training whether they want to reduce or stop their cannabis use. However, certain settings at which the training is tested officially require absolute consume stops (e.g. prisons), yet this is a characteristic of the respective institution and not of the training itself. After completing the CAN Stop training, certificates are handed out to participants who, participated at least at five out of eight group training sessions, for further gratification. If within a group, only three or less participants remain after other participants dropped out of the group, the group is not further continued. Control participants receive the respective treatment as usual, which the setting, the person is in usually provides. After the follow-up assessment, participants are invited to take part at a CAN Stop group training if they wish to attend. Timepoints: t0 (pre) = before the training/ treatment as usual t1 (post) = after the training/ treatment as usual which is 3 months after t0 t2 (follow-up) = 6 months after t1 |
Intervention type | Other |
Primary outcome measure | 1. Cannabis use in the past 30 days 2. In case of ongoing cannabis use: approximate weight of used cannabis on a day with mean cannabis use Measured at t0, t1 and t2 |
Secondary outcome measures | 1. Motivation to change existing cannabis use 2. Cannabis abstinence-related self-efficacy 3. Psychosocial adjustment 4. Behaviour in the face of peer pressure with regard to cannabis use Measured at t0, t1 and t2 |
Overall study start date | 15/02/2011 |
Completion date | 31/10/2011 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Other |
Sex | Both |
Target number of participants | n = 119 |
Key inclusion criteria | 1. Aged between 14 and 21 years, either sex 2. Cannabis consumed is deemed problematic by the young cannabis user or significant persons in his or her context (e.g. parents, teachers) 3. Participant's willingness to at least think over previous consumption patterns and to participate at a group dealing with the topic 4. Informed consent of participants and in the case of underage participants the informed consent of a parent or official guardian |
Key exclusion criteria | Acute symptoms of psychosis or suicidality. These exclusion criteria were checked via standardised screening questions at the beginning of the face-to-face take-in talks at the respective cooperation partner's institutions. |
Date of first enrolment | 15/02/2011 |
Date of final enrolment | 31/10/2011 |
Locations
Countries of recruitment
- Germany
Study participating centre
DZSKJ
Hamburg
20246
Germany
20246
Germany
Sponsor information
German Federal Ministry of Health (Bundesministerium fur Gesundheit [BMG]) (Germany)
Government
Government
Division Addiction and Drugs
Friedrichstrasse 108
Berlin
10117
Germany
albert.kern@bmg.bund.de | |
Website | http://www.bmg.bund.de |
https://ror.org/05vp4ka74 |
Funders
Funder type
Government
German Federal Ministry of Health (Bundesministerium fur Gesundheit [BMG]) (Germany) (ref: AZ IIA5-2507DSM209)
No information available
University Medical Centre Hamburg-Eppendorf (Germany) - German Centre for Addiction Research in Children and Adolescents
No information available
University of Rostock (Germany) - Department for Child and Adolescent Psychiatry
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 18/04/2011 | 18/12/2020 | Yes | No |
Editorial Notes
18/12/2020: Publication reference added.